Effect of dexmedetomidine on its clearance: a pharmacokinetic model

被引:14
|
作者
Pypendop, B. H. [1 ]
Escobar, A. [1 ]
Siao, K. T. [1 ]
Stanley, S. D. [2 ]
Ilkiw, J. E. [1 ]
机构
[1] Univ Calif Davis, Dept Surg & Radiol Sci, Sch Vet Med, Davis, CA 95688 USA
[2] Calif Anim Hlth & Food Safety, KL Maddy Equine Analyt Chem Lab, Davis, CA USA
关键词
ISOFLURANE-ANESTHETIZED CATS; MEDETOMIDINE; RAT; DOG;
D O I
10.1111/j.1365-2885.2012.01383.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:89 / 91
页数:3
相关论文
共 50 条
  • [31] Pharmacokinetic/pharmacodynamic effects of dexmedetomidine in patients with hepatic failure
    Baughman, VL
    Cunningham, FE
    Layden, T
    Tonkovich, L
    ANESTHESIA AND ANALGESIA, 2000, 90 (02): : U231 - U231
  • [32] Effect of autoinduction and food on the pharmacokinetics of furmonertinib and its active metabolite characterized by a population pharmacokinetic model
    Zou, Hui-xi
    Zhang, Yu-feng
    Zhong, Da-fang
    Jiang, Yong
    Liu, Fei
    Zhao, Qian-yu
    Zuo, Zhong
    Zhang, Yi-fan
    Yan, Xiao-yu
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (07) : 1865 - 1874
  • [33] Effect of autoinduction and food on the pharmacokinetics of furmonertinib and its active metabolite characterized by a population pharmacokinetic model
    Hui-xi Zou
    Yu-feng Zhang
    Da-fang Zhong
    Yong Jiang
    Fei Liu
    Qian-yu Zhao
    Zhong Zuo
    Yi-fan Zhang
    Xiao-yu Yan
    Acta Pharmacologica Sinica, 2022, 43 : 1865 - 1874
  • [34] METFORMIN RATE OF ABSORPTION AND CLEARANCE IS AFFECTED BY GENETIC VARIANTS IN A POPULATION PHARMACOKINETIC MODEL.
    Stage, T. B.
    Brosen, K.
    Christensen, M. M.
    Guiastrennec, B.
    Kjellsson, M. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S84 - S84
  • [35] The estimation of clearance of iohexol: A generic pharmacokinetic model for kidney transplant patients and living donors
    Boussetta-Charfi, O.
    Drague, A.
    Thibaudin, D.
    Mariat, C.
    Delavenne, X.
    Balluet, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 9 - 10
  • [36] PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR THE RENAL CLEARANCE OF SALICYLURIC ACID AND THE INTERACTION WITH PHENOLSULFONPHTHALEIN IN THE DOG
    RUSSEL, FGM
    WOUTERSE, AC
    VANGINNEKEN, CAM
    DRUG METABOLISM AND DISPOSITION, 1987, 15 (05) : 695 - 701
  • [37] Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model
    Cubitt, Helen E.
    Yeo, Karen R.
    Howgate, Eleanor M.
    Rostami-Hodjegan, Amin
    Barter, Zoe E.
    XENOBIOTICA, 2011, 41 (08) : 623 - 638
  • [38] Neuroprotective effect of dexmedetomidine in a murine model of traumatic brain injury
    Jin Wu
    Todd Vogel
    Xiang Gao
    Bin Lin
    Charles Kulwin
    Jinhui Chen
    Scientific Reports, 8
  • [39] Antihyperalgesic effect of systemic dexmedetomidine and gabapentin in a rat model of monoarthritis
    Zhang, Wei-Shi
    Xu, Hua
    Xu, Bo
    Sun, Shan
    Deng, Xiao-Ming
    Zhang, Yu-Qiu
    BRAIN RESEARCH, 2009, 1264 : 57 - 66
  • [40] Pharmacokinetic–pharmacodynamic model for the anticholinergic effect of glycopyrrolate
    Jani Penttilä
    Antti Helminen
    Kirsti Luomala
    Harry Scheinin
    European Journal of Clinical Pharmacology, 2001, 57 : 153 - 158